Lymphangioleiomyomatosis—presence of receptor tyrosine kinases and the angiogenesis factor VEGF‐A as potential therapeutic targets
AUTOR(ES)
Watz*, Henrik
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2117228Documentos Relacionados
- Dioxin Receptor Deficiency Impairs Angiogenesis by a Mechanism Involving VEGF-A Depletion in the Endothelium and Transforming Growth Factor-β Overexpression in the Stroma*
- Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins
- VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
- Gene targeting of VEGF-A in thymus epithelium disrupts thymus blood vessel architecture
- Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases